Akums Drugs and Pharmaceuticals Limited (NSE:AKUMS)

Market Cap	79.62B -2.7%
Revenue (ttm)	43.59B +8.9%
Net Income	2.55B -24.5%
EPS	16.67 -26.3%
Shares Out	153.10M
PE Ratio	31.20
Forward PE	22.71
Dividend	1.00 (0.19%)
Ex-Dividend Date	n/a

Volume	221,540
Average Volume	278,786
Open	523.50
Previous Close	521.35
Day's Range	516.60 - 525.45
52-Week Range	409.30 - 622.95
Beta	n/a
RSI	47.31
Earnings Date	May 14, 2026

About NSE:AKUMS

Akums Drugs and Pharmaceuticals Limited manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally. The company provides drugs, ayurvedic, herbals, toiletries, nutraceuticals, food and dietary supplements, derma and cosmetics, healthcare and hospital products, over-the-counter (OTC) products, active pharmaceutical ingredients, excipients, and compounds. It also offers branded formulations on various dosage forms, including tablets, capsules, injectables, opthalmics, and soft gelatin capsules f...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2004
• Employees: 7,536
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: AKUMS

Financial Performance

In fiscal year 2026, NSE:AKUMS's revenue was 44.88 billion, an increase of 8.90% compared to the previous year's 41.21 billion. Earnings were 2.55 billion, a decrease of -24.54%.